- Investing Ideas
- Indian Pharmaceuticals & Biotech Large Cap High Growth Potential
Indian Pharmaceuticals & Biotech Large Cap High Growth Potential
Results
2
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
2 companies
Torrent Pharmaceuticals
Market Cap: ₹1.5t
Engages in the research, development, manufacturing, marketing, and distribution of branded and generic pharmaceutical formulations in India, the United States, Brazil, Germany, and internationally.
500420
₹4,571.90
7D
4.0%
1Y
43.4%
Divi's Laboratories
Market Cap: ₹1.8t
Engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.
DIVISLAB
₹6,756.50
7D
-1.1%
1Y
0.3%